Mirion Technologies Inc. reported first‑quarter 2026 revenue of $257.6 million, a 27.5% year‑over‑year increase that beat the consensus estimate of $244.8 million. Adjusted earnings per share were $0.10, matching the $0.09–$0.0954 consensus. The company’s adjusted EBITDA margin contracted to 21.1% from 23.1% in Q1 2025, and adjusted free cash flow was $11 million, far below the $155–$175 million range that the company had previously guided for the full year.
Revenue growth was driven by a 39% rise in the Nuclear & Safety segment to $186 million, supported by a 15% organic increase in nuclear power orders. The Medical segment grew 5% to $72 million, with organic growth of roughly 4%. Adjusted EBITDA for the Medical segment was $24.6 million, close to analyst expectations of $24.68 million.
Margin compression was largely attributable to the dilutive impact of the Paragon and Certrec acquisitions, unfavorable mix effects, and one‑time items in the legacy sensing business. Paragon’s contribution to orders and backlog growth was highlighted, but the integration has yet to fully offset the short‑term cost and mix pressures.
Management lowered the full‑year 2026 adjusted EPS guidance to $0.48–$0.55 from the previously expected $0.50–$0.57, citing a special one‑time CEO retention grant of performance‑vesting stock options. Sales guidance remained unchanged at $1.129 billion–$1.147 billion, and the company reaffirmed its adjusted free‑cash‑flow guidance of $155–$175 million. CEO Thomas Logan said, “Paragon is the ‘tip of the spear’ for growing installed base dynamics. Integration is on‑pace, and we are already realizing commercial synergies.”
The market reacted with a 2% after‑hours dip, driven primarily by the downward revision of the EPS guidance. Investors focused on the impact of the non‑cash retention grant on profitability outlook, despite the company’s strong revenue performance.
Looking forward, Mirion remains confident in the nuclear power market, with a growing SMR pipeline and stabilizing headwinds in the medical segment. The company’s long‑term goal of achieving 30%+ EBITDA margins by 2028 is supported by ongoing cost‑control initiatives and AI‑driven efficiencies, but short‑term margin pressure from recent acquisitions will likely persist until integration matures.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.